{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T19:22:08Z","timestamp":1792092128756,"version":"4.4.0"},"reference-count":35,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T00:00:00Z","timestamp":1745971200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Public Health"],"abstract":"<jats:sec><jats:title>Objectives<\/jats:title><jats:p>This study aims to comprehensively analyze temporal trends in the burden of malignant melanoma (MM) in East Asia, focusing on incidence, prevalence, mortality, and disability-adjusted life years (DALYs) from 1991 to 2021. It further seeks to compare these trends with the global burden of disease.<\/jats:p><\/jats:sec><jats:sec><jats:title>Study design<\/jats:title><jats:p>The study utilized data from the Global Burden of Disease (GBD) database to examine the disease burden of MM across East Asian countries and regions, as well as globally, over a 30-year period (1991\u20132021).<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We assessed changes in the incidence, prevalence, mortality, and DALYs associated with MM in East Asia and globally using GBD database open-source data. To capture the underlying trends in the disease burden, we applied the Joinpoint regression model to calculate the average annual percentage change (AAPC) and corresponding 95% confidence intervals (95% CI). A detailed comparative analysis was conducted to explore differences in the burden of MM across East Asian regions and compared with global trends, with particular emphasis on age, sex, and temporal changes.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The greatest increase in MM incidence in East Asia was observed in Korea, where the age-standardized incidence rate (ASIR) rose from 0.603 cases per 100,000 population (95% CI: 0.389\u20130.789) in 1991 to 1.896 cases per 100,000 (95% CI: 0.78\u20132.499) in 2021. Regarding prevalence, China exhibited the most significant increase in East Asia, with the age-standardized prevalence rate (ASPR) increasing from 0.699 (95% CI: 0.451\u20130.864) per 100,000 in 1991 to 4.157 (95% CI: 2.195\u20135.633) per 100,000 in 2021. The highest increases in MM mortality and DALYs were noted in Taiwan Province of China, where the age-standardized mortality rate (ASMR) increased from 0.36 (95% CI: 0.339\u20130.382) per 100,000 in 1991 to 0.414 (95% CI: 0.414) per 100,000 in 2021. Similarly, the age-standardized DALY rate (ASDR) in Taiwan rose from 10.375 (95% CI: 9.781\u201311.049) per 100,000 in 1991 to 11.647 (95% CI: 10.558\u201312.478) per 100,000 in 2021. Age and gender exhibited distinct patterns of influence on the MM burden: while ASIR generally increased with age, ASPR initially increased and later plateaued. Both ASMR and ASDR demonstrated a positive correlation with age. Additionally, male populations consistently exhibited higher morbidity and mortality rates than females.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Over the period from 1991 to 2021, there were significant variations in the incidence, prevalence, mortality, and DALY rates of MM across East Asian countries and regions, including China, Japan, South Korea, North Korea, and Taiwan. These disparities underscore the need for region-specific, proactive prevention strategies and targeted public health interventions to mitigate the growing burden of malignant melanoma in the region.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fpubh.2025.1487177","type":"journal-article","created":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T05:38:28Z","timestamp":1745991508000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Analysis and comparison of the trends in burden of malignant cutaneous melanoma in East Asian countries and regions and worldwide from 1991 to 2021"],"prefix":"10.3389","volume":"13","author":[{"given":"Jiaxiang","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuanjun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangshuai","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,4,30]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/S0140-6736(23)00821-8","article-title":"Cutaneous melanoma","volume":"402","author":"Long","year":"2023","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/nrc.2016.37","article-title":"From melanocytes to melanomas","volume":"16","author":"Shain","year":"2016","journal-title":"Nat Rev Cancer"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1111\/bjd.21649","article-title":"The effect of screening on melanoma incidence and biopsy rates","volume":"187","author":"Whiteman","year":"2022","journal-title":"Br J Dermatol"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1001\/jamadermatol.2021.3884","article-title":"Association between melanoma detected during routine skin checks and mortality","volume":"157","author":"Watts","year":"2021","journal-title":"JAMA Dermatol"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1186\/s12872-023-03552-w","article-title":"Analysis and comparison of the trends in burden of rheumatic heart disease in China and worldwide from 1990 to 2019","volume":"23","author":"Shi","year":"2023","journal-title":"BMC Cardiovasc Disord"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1016\/j.jaad.2020.07.125","article-title":"The impact of demographics, socioeconomics, and health care access on melanoma outcomes","volume":"84","author":"Cortez","year":"2021","journal-title":"J Am Acad Dermatol"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1038\/s41591-022-01990-1","article-title":"The global burden of disease study at 30 years","volume":"28","author":"Murray","year":"2022","journal-title":"Nat Med"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1016\/S0140-6736(18)32225-6","article-title":"Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990-2017: a systematic analysis for the global burden of disease study 2017","volume":"392","author":"Stanaway","year":"2018","journal-title":"Lancet"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1016\/S0140-6736(20)30925-9","article-title":"Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the global burden of disease study 2019","volume":"396","year":"2020","journal-title":"Lancet"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1111\/bjd.15510","article-title":"The global burden of melanoma: results from the global burden of disease study 2015","volume":"177","author":"Karimkhani","year":"2017","journal-title":"Br J Dermatol"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1111\/bjd.15688","article-title":"Beyond country-specific incidence and mortality: the global burden of melanoma","volume":"178","author":"Bell","year":"2018","journal-title":"Br J Dermatol"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1001\/jamadermatol.2022.0160","article-title":"Global burden of cutaneous melanoma in 2020 and projections to 2040","volume":"158","author":"Arnold","year":"2022","journal-title":"JAMA Dermatol"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1007\/s10552-016-0738-1","article-title":"Characteristics, rates, and trends of melanoma incidence among Hispanics in the USA","volume":"27","author":"Garnett","year":"2016","journal-title":"Cancer Causes Control"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"4905","DOI":"10.1002\/cam4.4046","article-title":"Global, regional and national incidence, mortality and disability-adjusted life-years of skin cancers and trend analysis from 1990 to 2019: an analysis of the global burden of disease study 2019","volume":"10","author":"Zhang","year":"2021","journal-title":"Cancer Med"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"k 1079","DOI":"10.1136\/bmj.k1079","article-title":"TIDieR-PHP: a reporting guideline for population health and policy interventions","volume":"361","author":"Campbell","year":"2018","journal-title":"BMJ"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"16367","DOI":"10.1038\/s41598-020-73534-x","article-title":"Clinical features and survival outcomes of ocular melanoma in a multi-ethnic Asian cohort","volume":"10","author":"Tan","year":"2020","journal-title":"Sci Rep"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"993","DOI":"10.3109\/0284186X.2016.1144934","article-title":"Cutaneous malignant melanoma show geographic and socioeconomic disparities in stage at diagnosis and excess mortality","volume":"55","author":"Str\u00f6mberg","year":"2016","journal-title":"Acta Oncol"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"Cd012352","DOI":"10.1002\/14651858.CD012352.pub2","article-title":"Screening for reducing morbidity and mortality in malignant melanoma","volume":"6","author":"Johansson","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1093\/jnci\/djaa088","article-title":"Multiple primary melanoma incidence trends over five decades: a Nationwide population-based study","volume":"113","author":"Helgadottir","year":"2021","journal-title":"J Natl Cancer Inst"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1002\/cncr.33307","article-title":"Indoor tanning exposure in association with multiple primary melanoma","volume":"127","author":"Karapetyan","year":"2021","journal-title":"Cancer"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1097\/DSS.0000000000000188","article-title":"Increased burden of melanoma and nonmelanoma skin cancer in young women","volume":"40","author":"Evans","year":"2014","journal-title":"Dermatologic Surg"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1097\/CMR.0000000000000375","article-title":"Characteristics of melanoma in Japan: a nationwide registry analysis 2011-2013","volume":"27","author":"Tomizuka","year":"2017","journal-title":"Melanoma Res"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1097\/COC.0000000000000605","article-title":"National Burden of hospitalization due to cutaneous melanoma in adolescents and young adults","volume":"42","author":"Tripathi","year":"2019","journal-title":"Am J Clin Oncol"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jaad.2018.03.053","article-title":"Current controversies in early-stage melanoma: questions on incidence, screening, and histologic regression","volume":"80","author":"Gardner","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1002\/ijc.32764","article-title":"Burden of melanoma in China, 1990-2017: findings from the 2017 global burden of disease study","volume":"147","author":"Wu","year":"2020","journal-title":"Int J Cancer"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.cell.2019.08.032","article-title":"UVB-induced tumor heterogeneity diminishes immune response in melanoma","volume":"179","author":"Wolf","year":"2019","journal-title":"Cell"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1111\/ajd.12373","article-title":"Skin protection behaviour and sex differences in melanoma location in patients with multiple primary melanomas","volume":"58","author":"Warren","year":"2017","journal-title":"Australas J Dermatol"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1001\/jamadermatol.2020.0470","article-title":"Evaluation of sex-specific incidence of melanoma","volume":"156","author":"Olsen","year":"2020","journal-title":"JAMA Dermatol"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1016\/j.jaad.2017.06.149","article-title":"A meta-analysis of nevus-associated melanoma: prevalence and practical implications","volume":"77","author":"Pampena","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1111\/jdv.14304","article-title":"Expression of G protein-coupled oestrogen receptor in melanoma and in pregnancy-associated melanoma","volume":"31","author":"F\u00e1bi\u00e1n","year":"2017","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/s00403-024-03046-5","article-title":"The burden of skin diseases in China: global burden of disease study 2019","volume":"316","author":"Kong","year":"2024","journal-title":"Arch Dermatol Res"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"e14537","DOI":"10.1111\/dth.14537","article-title":"Comparison of mortality and medical complications between older and younger malignant melanoma inpatients","volume":"34","author":"Patel","year":"2021","journal-title":"Dermatol Ther"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"108226","DOI":"10.1016\/j.envint.2023.108226","article-title":"Global, regional and national burdens of non-melanoma skin cancer attributable to occupational exposure to solar ultraviolet radiation for 183 countries, 2000-2019: a systematic analysis from the WHO\/ILO joint estimates of the work-related burden of disease and injury","volume":"181","author":"Pega","year":"2023","journal-title":"Environ Int"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1001\/jamadermatol.2020.1573","article-title":"The burden of skin and subcutaneous diseases in the United States from 1990 to 2017","volume":"156","author":"Laughter","year":"2020","journal-title":"JAMA Dermatol"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"421","DOI":"10.25259\/IJDVL_978_20","article-title":"The burden of skin diseases in India: global burden of disease study 2017","volume":"89","author":"Kavita","year":"2023","journal-title":"Indian J Dermatol Venereol Leprol"}],"container-title":["Frontiers in Public Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2025.1487177\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T05:38:28Z","timestamp":1745991508000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2025.1487177\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,30]]},"references-count":35,"alternative-id":["10.3389\/fpubh.2025.1487177"],"URL":"https:\/\/doi.org\/10.3389\/fpubh.2025.1487177","relation":{},"ISSN":["2296-2565"],"issn-type":[{"value":"2296-2565","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,30]]},"article-number":"1487177"}}